Alltracel Pharmaceuticals Announces Nanopeutics Agreement

Alltracel Pharmaceuticals Plc., (“Alltracel” or “the company”), the healthcare innovation group focused on oral care, wound care, cardiovascular health and dermal health markets, announces that its Nanopeutics subsidiary has signed a collaborative technology development agreement with ConvaTec, a world-leading manufacturer of ostomy and wound care products with a 25-year heritage of caring for patients.
Yahoo Finance